Bacterial secretions of nonpathogenic Escherichia coli elicit inflammatory pathways: A closer investigation of interkingdom signaling

mBio

Volumn 6, Issue 2, 2015, Pages

  Zargar, Amin ^a,b   Quan, David N ^a,b   Carter, Karen K ^a,b   Guo, Min ^c   Sintim, Herman O ^c   Payne, Gregory F ^a,b   Bentley, William E ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Bldg 142   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CYTOKINE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; ESCHERICHIA COLI PROTEIN;

ARTICLE; BACTERIAL SECRETION SYSTEM; BACTERIAL STRAIN; CONTROLLED STUDY; DOWN REGULATION; ESCHERICHIA COLI; ESCHERICHIA COLI BL21; ESCHERICHIA COLI W3110; FLAGELLUM; HUMAN; HUMAN CELL; INFLAMMATION; NEXT GENERATION SEQUENCING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION; CELL LINE; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION PROFILING; IMMUNOLOGY; PHYSIOLOGY; SECRETION (PROCESS);

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

CELL LINE; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION PROFILING; HUMANS; SIGNAL TRANSDUCTION;

EID: 84929398296     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00025-15     Document Type: Article

References (61)

1. Sekirov I, Russell SL, Antunes LC, Finlay BB. 2010. Gut microbiota in health and disease. Physiol Rev 90:859-904. http://dx.doi.org/10.1152/physrev.00045.2009.
2. Peterson LW, Artis D. 2014. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 14:141-153. http://dx.doi.org/10.1038/nri3608.
3. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118:229-241. http://dx.doi.org/10.1016/j.cell.2004.07.002.
4. Bansal T, Alaniz RC, Wood TK, Jayaraman A. 2010. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc Natl Acad Sci U S A 107:228-233. http://dx.doi.org/10.1073/pnas.0906112107.
5. Medzhitov R. 2001. Toll-like receptors and innate immunity. Nat Rev Immunol 1:135-145. http://dx.doi.org/10.1038/35100529.
6. Inohara N, Nuñez G. 2003. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3:371-382. http://dx.doi.org/10.1038/nri1086.
7. Creagh EM, O’Neill LA. 2006. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 27: 352-357. http://dx.doi.org/10.1016/j.it.2006.06.003.
8. Nord CE, Kager L, Heimdahl A. 1984. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med 76: 99-106. http://dx.doi.org/10.1016/0002-9343(84)90250-X.
9. Lyte M. 2013. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog 9:e1003726. http://dx.doi.org/10.1371/journal.ppat.1003726.
10. Curtis MM, Sperandio V. 2011. A complex relationship: the interaction among symbiotic microbes, invading pathogens, and their mammalian host. Mucosal Immunol 4:133-138. http://dx.doi.org/10.1038/mi.2010.89.
11. Hughes DT, Sperandio V. 2008. Inter-kingdom signalling: communication between bacteria and their hosts. Nat Rev Microbiol 6:111-120. http://dx.doi.org/10.1038/nrmicro1836.
12. Iyer LM, Aravind L, Coon SL, Klein DC, Koonin EV. 2004. Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role? Trends Genet 20:292-299. http://dx.doi.org/10.1016/j.tig.2004.05.007.
13. Rutherford ST, Bassler BL. 2012. Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med 2:a012427. http://dx.doi.org/10.1101/cshperspect.a012427.
14. Rasko DA, Sperandio V. 2010. Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9:117-128. http://dx.doi.org/10.1038/nrd3013.
15. Borruel N, Casellas F, Antolín M, Llopis M, Carol M, Espíin E, Naval J, Guarner F, Malagelada JR. 2003. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am J Gastroenterol 98: 865-870. http://dx.doi.org/10.1111/j.1572-0241.2003.07384.x.
16. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S. 2004. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat Immunol 5:104-112. http://dx.doi.org/10.1038/ni1018.
17. Haller D, Bode C, Hammes WP, Pfeifer AM, Schiffrin EJ, Blum S. 2000. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47:79-87. http://dx.doi.org/10.1136/gut.47.1.79.
18. Kamada N, Maeda K, Inoue N, Hisamatsu T, Okamoto S, Hong KS, Yamada T, Watanabe N, Tsuchimoto K, Ogata H, Hibi T. 2008. Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. Infect Immun 76:214-220. http://dx.doi.org/10.1128/IAI.01193-07.
19. Lammers KM, Helwig U, Swennen E, Rizzello F, Venturi A, Caramelli E, Kamm MA, Brigidi P, Gionchetti P, Campieri M. 2002. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol 97:1182-1186. http://dx.doi.org/10.1111/j.1572-0241.2002.05693.x.
20. Martinez-Medina M, Aldeguer X, Lopez-Siles M, González-Huix F, López-Oliu C, Dahbi G, Blanco JE, Blanco J, Garcia-Gil LJ, Darfeuille-Michaud A. 2009. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn’s disease. Inflamm Bowel Dis 15:872-882. http://dx.doi.org/10.1002/ibd.20860.
21. Wang Z, Gerstein M, Snyder M. 2009. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10:57-63. http://dx.doi.org/10.1038/nrg2484.
22. Yoon SH, Han MJ, Jeong H, Lee CH, Xia XX, Lee DH, Shim JH, Lee SY, Oh TK, Kim JF. 2012. Comparative multi-omics systems analysis of Escherichia coli strains B and K-12. Genome Biol 13:R37. http://dx.doi.org/10.1186/gb-2012-13-5-r37.
23. Yoon S, et al. 2009. Genomics, biological features, and biotechnological applications of Escherichia coli B: “is B for better?!,” p 1-17. In Lee S (ed), Systems biology and biotechnology of Escherichia coli. Springer, Amsterdam, Netherlands.
24. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. 2012. Diversity, stability and resilience of the human gut microbiota. Nature 489:220-230. http://dx.doi.org/10.1038/nature11550.
25. Baruch M, Belotserkovsky I, Hertzog BB, Ravins M, Dov E, McIver KS, Le Breton YS, Zhou Y, Cheng CY, Chen CY, Hanski E. 2014. An extracellular bacterial pathogen modulates host metabolism to regulate its own sensing and proliferation. Cell 156:97-108. http://dx.doi.org/10.1016/j.cell.2013.12.007.
26. Kendall MM, Gruber CC, Parker CT, Sperandio V. 2012. Ethanolamine controls expression of genes encoding components involved in interkingdom signaling and virulence in enterohemorrhagic Escherichia coli O157: H7. mBio 3:e00050-12. http://dx.doi.org/10.1128/mBio.00050-12.
27. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-Seq. BioInformatics 25:1105-1111. http://dx.doi.org/10.1093/bioinformatics/btp120.
28. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25. http://dx.doi.org/10.1186/gb-2009-10-3-r25.
29. Anders S, Huber W. 2010. Differential expression analysis for sequence count data. Genome Biol 11:R106. http://dx.doi.org/10.1186/gb-2010-11-10-r106.
30. Tarca AL, Draghici S, Khatri P, Hassan SS, Mittal P, Kim JS, Kim CJ, Kusanovic JP, Romero R. 2009. A novel signaling pathway impact analysis. Bioinformatics 25:75-82. http://dx.doi.org/10.1093/bioinformatics/btn577.
31. Swamy M, Jamora C, Havran W, Hayday A. 2010. Epithelial decision makers: in search of the epimmunome. Nat Immunol 11:656-665. http://dx.doi.org/10.1038/ni.1905.
32. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. 2001. Decreased expression of toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 167:1609-1616. http://dx.doi.org/10.4049/jimmunol.167.3.1609.
33. Naik S, Kelly EJ, Meijer L, Pettersson S, Sanderson IR. 2001. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr 32:449-453. http://dx.doi.org/10.1097/00005176-200104000-00011.
34. Suzuki M, Hisamatsu T, Podolsky DK. 2003. Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infect Immun 71:3503-3511. http://dx.doi.org/10.1128/IAI.71.6.3503-3511.2003.
35. Jeon HJ, Choi JH, Jung IH, Park JG, Lee MR, Lee MN, Kim B, Yoo JY, Jeong SJ, Kim DY, Park JE, Park HY, Kwack K, Choi BK, Kwon BS, Oh GT. 2010. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation 121:1124-1133. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.882704.
36. Liew FY, Xu D, Brint EK, O’Neill LA. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol 5:446-458. http://dx.doi.org/10.1038/nri1630.
37. Perkins ND. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8:49-62. http://dx.doi.org/10.1038/nrm2083.
38. Ma A, Malynn BA. 2012. A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat Rev Immunol 12:774-785. http://dx.doi.org/10.1038/nri3313.
39. Vereecke L, Beyaert R, van Loo G. 2009. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 30:383-391. http://dx.doi.org/10.1016/j.it.2009.05.007.
40. Hausmann E, Raisz LG, Miller WA. 1970. Endotoxin: stimulation of bone resorption in tissue culture. Science 168:862-864. http://dx.doi.org/10.1126/science.168.3933.862.
41. Ishihara Y, Nishihara T, Maki E, Noguchi T, Koga T. 1991. Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide. J Periodontal Res 26:155-160. http://dx.doi.org/10.1111/j.1600-0765.1991.tb01639.x.
42. Angrisano T, Pero R, Peluso S, Keller S, Sacchetti S, Bruni CB, Chiariotti L, Lembo F. 2010. LPS-induced IL-8 activation in human intestinal epithelial cells is accompanied by specific histone H3 acetylation and methylation changes. BMC Microbiol 10:172. http://dx.doi.org/10.1186/1471-2180-10-172.
43. Pugin J, Schürer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad SciUSA90:2744-2748. http://dx.doi.org/10.1073/pnas.90.7.2744.
44. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK. 2000. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164:966-972. http://dx.doi.org/10.4049/jimmunol.164.2.966.
45. Studier FW, Studier FW, Daegelen P, Lenski RE, Maslov S, Kim JF. 2009. Understanding the differences between genome sequences of Escherichia coli B strains REL606 and BL21(DE3) and comparison of the E. coli B and K-12 genomes. J Mol Biol 394:-653-680. http://dx.doi.org/10.1016/j.jmb.2009.09.021.
46. Quan DN, Bentley WE. 2012. Gene network homology in prokaryotes using a similarity search approach: queries of quorum sensing signal transduction. PLoS Comput Biol 8:e1002637. http://dx.doi.org/10.1371/journal.pcbi.1002637.
47. Pereira CS, de Regt AK, Brito PH, Miller ST, Xavier KB. 2009. Identification of functional LsrB-like autoinducer-2 receptors. J Bacteriol 191: 6975-6987. http://dx.doi.org/10.1128/JB.00976-09.
48. Li J, Wang L, Hashimoto Y, Tsao CY, Wood TK, Valdes JJ, Zafiriou E, Bentley WE. 2006. A stochastic model of Escherichia coli AI-2 quorum signal circuit reveals alternative synthesis pathways. Mol Syst Biol 2:67.
49. Ng WL, Bassler BL. 2009. Bacterial quorum-sensing network architectures. Annu Rev Genet 43:197-222. http://dx.doi.org/10.1146/annurev-genet-102108-134304.
50. Jayaraman A, Wood TK. 2008. Bacterial quorum sensing: signals, circuits, and implications for biofilms and disease. AnnuRev Biomed Eng 10:145-167. http://dx.doi.org/10.1146/annurev.bioeng.10.061807.160536.
51. Ahmer BM. 2004. Cell-to-cell signalling in Escherichia coli and Salmonella enterica. Mol Microbiol 52:933-945. http://dx.doi.org/10.1111/j.1365-2958.2004.04054.x.
52. Walters M, Sperandio V. 2006. Quorum sensing in Escherichia coli and salmonella. Int J Med Microbiol 296:125-131. http://dx.doi.org/10.1016/j.ijmm.2006.01.041.
53. Mota LJ, Cornelis GR. 2005. The bacterial injection kit: type III secretion systems. Ann Med 37:234-249. http://dx.doi.org/10.1080/07853890510037329.
54. Tateda K, Ishii Y, Horikawa M, Matsumoto T, Miyairi S, Pechere JC, Standiford TJ, Ishiguro M, Yamaguchi K. 2003. The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils. Infect Immun 71: 5785-5793. http://dx.doi.org/10.1128/IAI.71.10.5785-5793.2003.
55. Shiner EK, Terentyev D, Bryan A, Sennoune S, Martinez-Zaguilan R, Li G, Gyorke S, Williams SC, Rumbaugh KP. 2006. Pseudomonas aeruginosa autoinducer modulates host cell responses through calcium signalling. Cell Microbiol 8:1601-1610. http://dx.doi.org/10.1111/j.1462-5822.2006.00734.x.
56. Bryan A, Watters C, Koenig L, Youn E, Olmos A, Li G, Williams SC, Rumbaugh KP. 2010. Human transcriptome analysis reveals a potential role for active transport in the metabolism of Pseudomonas aeruginosa autoinducers. Microbes Infect 12:1042-1050. http://dx.doi.org/10.1016/j.micinf.2010.07.006.
57. Karlin DA, Mastromarino AJ, Jones RD, Stroehlein JR, Lorentz O. 1985. Fecal skatole and indole and breath methane and hydrogen in patients with large bowel polyps or cancer. J Cancer Res Clin Oncol 109: 135-141. http://dx.doi.org/10.1007/BF00391888.
58. Zuccato E, Venturi M, Di Leo G, Colombo L, Bertolo C, Doldi SB, Mussini E. 1993. Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy. Dig Dis Sci 38:514-519. http://dx.doi.org/10.1007/BF01316508.
59. Zhu J, Pei D. 2008. A LuxP-based fluorescent sensor for bacterial autoinducer II. ACS Chem Biol 3:110-119. http://dx.doi.org/10.1021/cb7002048.
60. Charlton TS, de Nys R, Netting A, Kumar N, Hentzer M, Givskov M, Kjelleberg S. 2000. A novel and sensitive method for the quantification of N-3-oxoacyl homoserine lactones using gas chromatography-mass spectrometry: application to a model bacterial biofilm. Environ Microbiol 2:530-541. http://dx.doi.org/10.1046/j.1462-2920.2000.00136.x.
61. Bassler BL, Greenberg EP, Stevens AM. 1997. Cross-species induction of luminescence in the quorum-sensing bacterium Vibrio harveyi. J Bacteriol 179:4043-4045.